Specialists of the Siberian Federal University and the Federal Research Centre ‘Krasnoyarsk Science Centre of the Siberian Branch of the Russian Academy of Sciences’ have developed a method for treating iron deficiency anemia using ferrihydrite nanoparticles. The results of the study were published in the Medical Immunology journal.
The scientists told about the use of magnetic ferrihydrite nanoparticles, which attracted the attention of specialists for their natural origin, as well as magnetic properties. During the study, such particles were introduced into living cells isolated from the blood of 29 conditionally healthy donors. The scientists compared the characteristics of the cells before the experiment and after it was conducted.
It turned out that depending on the concentration, ferrihydrite nanoparticles can both suppress the normal functioning of blood cells and stimulate it, promoting hematopoiesis. Due to the magnetic properties of such particles, they can also be made “couriers” for the targeted delivery of drugs specifically to the affected organ. It is specified that the study is still in the process of development.